Performance of the CareStart™ G6PD deficiency screening test, a point-of-care diagnostic for primaquine therapy screening.
Development of reliable, easy-to-use, rapid diagnostic tests (RDTs) to detect glucose-6-phosphate dehydrogenase (G6PD) deficiency at point of care is essential to deploying primaquine therapies as part of malaria elimination strategies. We assessed a kit under research and development called CareSta...
Main Authors: | Saorin Kim, Chea Nguon, Bertrand Guillard, Socheat Duong, Sophy Chy, Sarorn Sum, Sina Nhem, Christiane Bouchier, Magali Tichit, Eva Christophel, Walter R J Taylor, John Kevin Baird, Didier Menard |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3229584?pdf=render |
Similar Items
-
Performance of “VIKIA Malaria Ag Pf/Pan” (IMACCESS®), a new malaria rapid diagnostic test for detection of symptomatic malaria infections
by: Chou Monidarin, et al.
Published: (2012-08-01) -
Assessment of CareStart G6PD rapid diagnostic test and CareStart G6PD biosensor in Mauritania
by: Oum Kelthoum Mamadou Djigo, et al.
Published: (2021-08-01) -
Focused Screening and Treatment (FSAT): a PCR-based strategy to detect malaria parasite carriers and contain drug resistant P. falciparum, Pailin, Cambodia.
by: Stefan Hoyer, et al.
Published: (2012-01-01) -
Evaluation of the CareStart™ glucose-6-phosphate dehydrogenase (G6PD) rapid diagnostic test in the field settings and assessment of perceived risk from primaquine at the community level in Cambodia.
by: Bertha Wojnarski, et al.
Published: (2020-01-01) -
Concurrence of CareStart™ Malaria HRP2 RDT with microscopy in population screening for Plasmodium falciparum infection in the Mount Cameroon area: predictors for RDT positivity
by: Rene Ning Teh, et al.
Published: (2019-03-01)